Jason Sapsin was quoted in the Med City News article "Five Ways the Government Shutdown is Bad for Health Care and Life Science Companies." While the full text can be found in the October 2, 2013, issue of Med City News, a synopsis is noted below.
The government shutdown could harm small, emerging companies, but if prolonged, the ramifications for the health care and life science industries could expand considerably.
The shutdown could cause product development delays, says Jason Sapsin. "If you are a life science company and trying to get product to market and you need to communicate with people to get that issue resolved, it makes it impossible if staff are not there and this is critical."
The shutdown could also make scientists rethink their careers, Sapsin says. "The longer funding is constricted, young scientists will look at other fields. They will wonder how they'll feed themselves, pay for their education and living expenses. They will think about new career paths... where they can have greater control over our destinies. That can last for a long time."
Other ramifications of a prolonged shutdown could include new clinical trial candidates being turned away, the resurgence in IPOs could dwindle and an impact could be felt on physician training.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
